Head-to-head · WeighScore
Auren Rx vs RENN Health
The verdict
Auren Rx takes it — 72.9/100 to 69.3/100.
Auren Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Auren Rx charges the same $149 for semaglutide and tirzepatide, which removes the usual reason to start on the weaker molecule.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Auren Rx | RENN Health |
|---|---|---|
| WeighScore | 72.9/100 | 69.3/100 |
| Grade | C | C |
| Site position | #83 | #145 |
| Semaglutide | $149/mo (auto-refill; a single month with no commitment is $179) | From $149/mo (the site's own floor; it publishes no billing cycle and no standing rate) |
| Tirzepatide | $149/mo (auto-refill; a single month with no commitment is $179) | From $199/mo (the site's own floor; it publishes no billing cycle and no standing rate) |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #83 · C
Strengths
- Semaglutide and tirzepatide cost the same, so the choice of molecule is clinical rather than budgetary
- A microdose lane is priced separately at $129 on auto-refill rather than folded into the standard figure
- Names its dispensing pharmacy, VialsRX, with a street address and a phone number in Houston, Texas
- Names a prescribing physician and practice, and publishes support hours of Monday to Friday, 9 AM to 6 PM Eastern
Where it loses points
- The $149 figure requires enrolling in auto-refill; a single month with no commitment is $179
- Two different medical groups are named for the same service — Wasef Health, PC on the contact page and FAQ, Beluga Health, P.A. in the telehealth consent
- Product pages advertise a free online visit while the Terms make the initial online visit and any laboratory testing the patient's responsibility
- The FAQ says all 50 states, the Terms say service is available only in certain states, and no list is published
- No compounding class is stated for VialsRX, so whether it operates under 503A or 503B is unknown
- NAD+ is priced at two different figures on the same site, which is not reassuring about the GLP-1 numbers
Site position #145 · C
Strengths
- Names six dispensing pharmacies with websites and phone numbers — Belmar, Strive, Epiq Scripts, Casa Pharma Rx, The Pharmacy Hub and Foothills
- Names two prescribing physicians with their NPI numbers and the medical group behind them, which almost nothing else at this price does
- Prices a registered dietitian, the telehealth visit and overnight cold shipping at zero rather than adding them later
- Care is stated as available to patients in all 50 U.S. states
Where it loses points
- No refund, cancellation or auto-renewal terms exist anywhere on the site, on a subscription product sold with three- and six-month prepay bundles
- “As low as $149” and “as low as $199” are floors with no billing cycle attached, and the site never states what the standing monthly rate is or what the floor requires
- The memberships page ships placeholder text — “Membership 1 / short description placeholder” and the word Placeholder where a price belongs — and it is in the site's own sitemap
- The word compounded never appears on the marketing site; the disclosure exists only in an interface the patient does not see
- Semaglutide and tirzepatide tablets are marked visible in the patient's own intake catalog and appear nowhere on the public site
- The Terms carry two governing-law clauses that name different jurisdictions
- Belmar, one of the six named dispensing pharmacies, is the subject of an FDA warning letter issued March 2023 to “Belmar Pharma Solutions, Drug Depot, LLC., dba APS Pharmacy”, which the FDA closed out in October 2023. It concerns a supplier; RENN Health carries no warning letter of its own
- No compounding class is stated for any of the six pharmacies
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). CoreAge Rx advertises flat dose pricing for compounded injections, with no membership fee; its consultation-fee and refund deadlines deserve a close read before paying.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.